Literature DB >> 3014856

Validation of doubly labeled water for measuring energy expenditure during parenteral nutrition.

D A Schoeller, R F Kushner, P J Jones.   

Abstract

The doubly labeled water method was compared with intake-balance for measuring energy expenditure in five patients receiving total parenteral nutrition (TPN). Because parenteral solutions were isotopically different from local water, patients had to be placed on TPN at least 10 days before the metabolic period. Approximately 0.1 g 2H2O and 0.25 g H2(18)O per kg total body water were given orally. We collected saliva before, 3 h, and 4 h after the dose for measurement of total body water and urine before, 1 day, and 14 days after the dose for measurement of isotope eliminations. On day 14, total body weight was remeasured and change in body energy stores was calculated, assuming constant hydration. Intake was assessed from weights of TPN fluids plus dietary record for any oral intake. Energy expenditure from doubly labeled water (+/- SD) averaged 3 +/- 6% greater than intake-balance. Doubly labeled water method is a noninvasive, nonrestrictive method for measuring energy expenditure in patients receiving TPN.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014856     DOI: 10.1093/ajcn/44.2.291

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  9 in total

1.  Addressing Current Criticism Regarding the Value of Self-Report Dietary Data.

Authors:  Amy F Subar; Laurence S Freedman; Janet A Tooze; Sharon I Kirkpatrick; Carol Boushey; Marian L Neuhouser; Frances E Thompson; Nancy Potischman; Patricia M Guenther; Valerie Tarasuk; Jill Reedy; Susan M Krebs-Smith
Journal:  J Nutr       Date:  2015-10-14       Impact factor: 4.798

2.  Inter- and intraindividual correlations of background abundances of (2)H, (18)O and (17)O in human urine and implications for DLW measurements.

Authors:  E S F Berman; E L Melanson; T Swibas; S P Snaith; J R Speakman
Journal:  Eur J Clin Nutr       Date:  2015-03-25       Impact factor: 4.016

Review 3.  Metabolic basis for management of the septic surgical patient.

Authors:  J H Shaw; J B Koea
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

4.  The usefulness of an accelerometer for monitoring total energy expenditure and its clinical application for predicting body weight changes in type 2 diabetic korean women.

Authors:  Ji Yeon Jung; Kyung Ah Han; Hwi Ryun Kwon; Hee Jung Ahn; Jae Hyuk Lee; Kang Seo Park; Kyung Wan Min
Journal:  Korean Diabetes J       Date:  2010-12-31

5.  Effects of exercise mode, energy, and macronutrient interventions on inflammation during military training.

Authors:  Stefan M Pasiakos; Lee M Margolis; Nancy E Murphy; Holy L McClung; Svein Martini; Yngvar Gundersen; John W Castellani; James P Karl; Hilde K Teien; Elisabeth H Madslien; Pal H Stenberg; Andrew J Young; Scott J Montain; James P McClung
Journal:  Physiol Rep       Date:  2016-06

6.  Special Considerations for Measuring Energy Expenditure with Doubly Labeled Water under Atypical Conditions.

Authors:  Surabhi Bhutani; Natalie Racine; Tim Shriver; Dale A Schoeller
Journal:  J Obes Weight Loss Ther       Date:  2015-07-30

Review 7.  Traditional Self-Reported Dietary Instruments Are Prone to Inaccuracies and New Approaches Are Needed.

Authors:  Michele N Ravelli; Dale A Schoeller
Journal:  Front Nutr       Date:  2020-07-03

Review 8.  An objective measure of energy intake using the principle of energy balance.

Authors:  Michele N Ravelli; Dale A Schoeller
Journal:  Int J Obes (Lond)       Date:  2021-01-21       Impact factor: 5.095

9.  Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques.

Authors:  Paul Kievit; Heather Halem; Daniel L Marks; Jesse Z Dong; Maria M Glavas; Puspha Sinnayah; Lindsay Pranger; Michael A Cowley; Kevin L Grove; Michael D Culler
Journal:  Diabetes       Date:  2012-10-09       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.